aDepartment of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland

bDepartment of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, Virginia, USA

Received 8 April 2022 Revised form accepted 24 April 2022

Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website, www.anti-cancerdrugs.com.

Correspondence to Paul Dent, PhD, Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Massey Cancer Center, Box 980035, Richmond, VA 23298 0035, USA, Tel: +804 628 0861; e-mail: [email protected]